相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies
Catherine A. McCarty et al.
BMC MEDICAL GENOMICS (2011)
Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
L. A. Donnelly et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans
M. A. Perera et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The Emerging Role of Electronic Medical Records in Pharmacogenomics
R. A. Wilke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction
Marianne K. Kringen et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Genetically informed lung cancer medicine
William Pao et al.
JOURNAL OF PATHOLOGY (2011)
Charting a course for genomic medicine from base pairs to bedside
Eric D. Green et al.
NATURE (2011)
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Heleen J. Bouman et al.
NATURE MEDICINE (2011)
From expression QTLs to personalized transcriptomics
Stephen B. Montgomery et al.
NATURE REVIEWS GENETICS (2011)
Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Pei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
KIF6 Polymorphism as a Predictor of Risk of Coronary Events and of Clinical Event Reduction by Statin Therapy
Yonghong Li et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Combined Influence of LDLR and HMGCR Sequence Variation on Lipid-Lowering Response to Simvastatin
Lara M. Mangravite et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Letter by Gurbel et al Regarding Article, Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
Paul A. Gurbel et al.
CIRCULATION (2010)
Cardiovascular Networks Systems-Based Approaches to Cardiovascular Disease
Aldons J. Lusis et al.
CIRCULATION (2010)
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
Dirk Sibbing et al.
CIRCULATION (2010)
An alpha(2C)-Adrenergic Receptor Polymorphism Alters the Norepinephrine-Lowering Effects and Therapeutic Response of the beta-Blocker Bucindolol in Chronic Heart Failure
Michael R. Bristow et al.
CIRCULATION-HEART FAILURE (2010)
Common Variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 Genes as Predictors of Lipid-Lowering Response to Atorvastatin Therapy
Aruna Poduri et al.
DNA AND CELL BIOLOGY (2010)
KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study
Olga A. Iakoubova et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Validation and Comparison of Pharmacogenetics-Based Warfarin Dosing Algorithms for Application of Pharmacogenetic Testing
Nitin Roper et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Warfarin Genotyping Reduces Hospitalization Rates Results From the MM-WES (Medco-Mayo Warfarin Effectiveness Study)
Robert S. Epstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration A Systematic Meta-Analysis
Jean-Sebastien Hulot et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies
Themistocles L. Assimes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Chromosome 4q25 Variants and Atrial Fibrillation Recurrence After Catheter Ablation
Daniela Husser et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Polymorphisms in the NOS1AP Gene Modulate QT Interval Duration and Risk of Arrhythmias in the Long QT Syndrome
Marta Tomas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
Jessica L. Mega et al.
LANCET (2010)
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
Lars Wallentin et al.
LANCET (2010)
Genomewide Association Studies and Assessment of the Risk of Disease
Teri A. Manolio
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
Guillaume Pare et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular Disease
Gerald W. Dorn
PHYSIOLOGICAL REVIEWS (2010)
Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
Mathew J. Barber et al.
PLOS ONE (2010)
Pharmacogenomics of antihypertensive drugs: past, present and future
Julie A. Johnson
PHARMACOGENOMICS (2010)
Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin. Part 2: Clinical Studies
Chiara Lanzani et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Aspirin Resistance in Healthy Drug-Naive Men Versus Women (from the Heredity and Phenotype Intervention Heart Study)
Haiqing Shen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
The LDL Receptor
Joseph L. Goldstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers
Matthijs L. Becker et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Drug-Sensitized Zebrafish Screen Identifies Multiple Genes, Including GINS3, as Regulators of Myocardial Repolarization
David J. Milan et al.
CIRCULATION (2009)
Clopidogrel and the Concept of High-Risk Pharmacokinetics
Dan M. Roden et al.
CIRCULATION (2009)
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
Jessica L. Mega et al.
CIRCULATION (2009)
Genetic Variations in Nitric Oxide Synthase 1 Adaptor Protein Are Associated With Sudden Cardiac Death in US White Community-Based Populations
W. H. Linda Kao et al.
CIRCULATION (2009)
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome
Lia Crotti et al.
CIRCULATION (2009)
Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome
Hideki Itoh et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2009)
Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
John F. Thompson et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
CACNA1C Gene Polymorphisms, Cardiovascular Disease Outcomes, and Treatment Response
Amber L. Beitelshees et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer A Dose-Escalation Study
Patrick Gladding et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Validation of Clinical Testing for Warfarin Sensitivity Comparison of CYP2C9-VKORC1 Genotyping Assays and Warfarin-Dosing Algorithms
Michael R. Langley et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
The SLCO1B1*5 Genetic Variant Is Associated With Statin-Induced Side Effects
Deepak Voora et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
Jean-Philippe Collet et al.
LANCET (2009)
CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
Matthew G. McDonald et al.
MOLECULAR PHARMACOLOGY (2009)
Common variants at ten loci modulate the QT interval duration in the QTSCD Study
Arne Pfeufer et al.
NATURE GENETICS (2009)
Common variants at ten loci influence QT interval duration in the QTGEN Study
Christopher Newton-Cheh et al.
NATURE GENETICS (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal
Daniel Kurnik et al.
PHARMACOGENOMICS (2009)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes:: Results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES)
Tobias Gerhard et al.
AMERICAN HEART JOURNAL (2008)
The genetic response to short-term interventions affecting cardiovascular function: Rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study
Braxton D. Mitchell et al.
AMERICAN HEART JOURNAL (2008)
Effect of cytochrome P450 polymorphisms on platelet reactivity after treatment with Clopidogrel in acute coronary syndrome
Corinne Frere et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Warfarin pharmacogenetics:: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations
Stuart A. Scott et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepository
Russell A. Wilke et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell et al.
BLOOD (2008)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Pharmacogenetics of aspirin resistance: a comprehensive systematic review
Timothy Goodman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment
Ronald M. Krauss et al.
CIRCULATION (2008)
Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme a reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin
Marisa Wong Medina et al.
CIRCULATION (2008)
Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel
Lukasz A. Malek et al.
CIRCULATION JOURNAL (2008)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: A possible mechanism for clopidogrel resistance
K. A. Kim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans
H. Schelleman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin
Yuan Gao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
beta(1)- and beta(2)-Adrenoceptor polymorphisms and cardiovascular diseases
Otto-Erich Brodde
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
Stephen T. Turner et al.
HYPERTENSION (2008)
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol
Amy J. Sehnert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
K. Umemura et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Variations in DNA elucidate molecular networks that cause disease
Yanqing Chen et al.
NATURE (2008)
A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure
Stephen B. Liggett et al.
NATURE MEDICINE (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A paucimorphic variant in the HMO-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study
Louise A. Donnelly et al.
PHARMACOGENETICS AND GENOMICS (2008)
CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
Tobias Geisler et al.
PHARMACOGENOMICS (2008)
Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans
Nita A. Limdi et al.
PHARMACOGENOMICS (2008)
CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart
Kuan-Cheng Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Zebrafish genetic models for arrhythmia
David J. Milan et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2008)
CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation:: A prospective randomized controlled study
Y. Caraco et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin
Na Limdi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Cytochrome P4502C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients
Betti Giusti et al.
PHARMACOGENETICS AND GENOMICS (2007)
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
J. T. Brandt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects
P. Fontana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Variants conferring risk of atrial fibrillation on chromosome 4q25
Daniel F. Gudbjartsson et al.
NATURE (2007)
Evaluation of dose-related effects of aspirin on platelet function - Results from the aspirin-induced platelet effect (ASPECT) study
Paul A. Gurbel et al.
CIRCULATION (2007)
Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1
Nauder Faraday et al.
CIRCULATION (2007)
Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Antihypertensive therapy, the α-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons:: the Genetics of Hypertension-Associated Treatment Study
B. R. Davis et al.
PHARMACOGENOMICS JOURNAL (2007)
Synergistic polymorphisms of β1 and α2c-adrenergic receptors and the influence on left ventricular ejection fraction response to β-blocker therapy in heart failure
Maximilian T. Lobmeyer et al.
PHARMACOGENETICS AND GENOMICS (2007)
The Pharmacogenetics Research Network: From SNP discovery to clinical drug response
K. M. Giacomini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Association of warfarin dose with genes involved in its action and metabolism
Mia Wadelius et al.
HUMAN GENETICS (2007)
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen et al.
PHARMACOGENETICS AND GENOMICS (2006)
Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
Jean-Sebastien Hulot et al.
BLOOD (2006)
A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure
Stephen B. Liggett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Drug insight: clopidogrel nonresponsiveness
Paul A. Gurbel et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2006)
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization
Dan E. Arking et al.
NATURE GENETICS (2006)
Phenotypic predictors of response to Simvastatin therapy among African-Americans and Caucasians:: The Cholesterol and Pharmaeogenetics (CAP) Study
JA Simon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Aspirin and clopidogrel resistance: an emerging clinical entity
TH Wang et al.
EUROPEAN HEART JOURNAL (2006)
Long QT syndrome: reduced repolarization reserve and the genetic link
DM Roden
JOURNAL OF INTERNAL MEDICINE (2006)
Combinatorial pharmacogenetics
RA Wilke et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage
RA Wilke et al.
PHARMACOGENETICS AND GENOMICS (2005)
Effect of clopidogrel and ticlopidine on cytochrome P4502B6 activity as measured by bupropion hydroxylation
M Turpeinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients
A Wang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients
ADC Paulussen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance
WC Lau et al.
CIRCULATION (2004)
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine
T Richter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Pharmacogenetic study of statin therapy and cholesterol reduction
DI Chasman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia
K Kajinami et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Gly389Arg polymorphism of β1-adenergic receptor is associated with the cardiovascular response to metoprolol
J Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
P Fontana et al.
CIRCULATION (2003)
β1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
JA Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity
PA Gurbel et al.
CIRCULATION (2003)
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
PA Gum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Synergistic polymorphisms of β1- and α2C-adrenergic receptors and the risk of congestive heart failure
KM Small et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes
P Yang et al.
CIRCULATION (2002)
Diuretic therapy, the α-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension
BM Psaty et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome
H Kanki et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2002)
Replication validity of genetic association studies
JPA Ioannidis et al.
NATURE GENETICS (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
分享论文
